0LC

(1R,2R)-N-(1-cyanocyclopropyl)-2-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)carbonyl]cyclohexanecarboxamide

Created:	2012-02-13
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 0LC is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	55
Chiral Atom Count	2
Bond Count	59
Aromatic Bond Count	10

2D diagram of 0LC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(1R,2R)-N-(1-cyanocyclopropyl)-2-[(8-fluoro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)carbonyl]cyclohexanecarboxamide
Systematic Name (OpenEye OEToolkits)	(1R,2R)-N-(1-cyanocyclopropyl)-2-[(8-fluoranyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)carbonyl]cyclohexane-1-carboxamide
Formula	C₂₃ H₂₅ F N₄ O₂
Molecular Weight	408.469
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	N#CC5(NC(=O)C4CCCCC4C(=O)N2Cc1c3c(nc1CC2)ccc(F)c3)CC5
SMILES	CACTVS	3.370	Fc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)[CH]4CCCC[CH]4C(=O)NC5(CC5)C#N
SMILES	OpenEye OEToolkits	1.7.6	c1cc2c(cc1F)c3c([nH]2)CCN(C3)C(=O)C4CCCCC4C(=O)NC5(CC5)C#N
Canonical SMILES	CACTVS	3.370	Fc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)[C@@H]4CCCC[C@H]4C(=O)NC5(CC5)C#N
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1cc2c(cc1F)c3c([nH]2)CCN(C3)C(=O)[C@@H]4CCCC[C@H]4C(=O)NC5(CC5)C#N
InChI	InChI	1.03	InChI=1S/C23H25FN4O2/c24-14-5-6-19-17(11-14)18-12-28(10-7-20(18)26-19)22(30)16-4-2-1-3-15(16)21(29)27-23(13-25)8-9-23/h5-6,11,15-16,26H,1-4,7-10,12H2,(H,27,29)/t15-,16-/m1/s1
InChIKey	InChI	1.03	HGJTURTZFKNELD-HZPDHXFCSA-N

Related Resource References

Resource Name	Reference
PubChem	25142042
ChEMBL	CHEMBL2164678

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.